- All
- Event Participitation (6)
- News & Press releases (5)
- Scientific Publication (2)
Event Participitation
Cycuria’s CEO, Dr. Nisit Khandelwal, to Present at the Upcoming BIO-Europe Conference in Vienna
Join our CEO as he presents Cycuria Therapeutics‘ latest advancements in oncology innovation at the upcoming BIO-Europe conference in Vienna . 📍 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗩𝗶𝗲𝗻𝗻𝗮 🗓️...
Event Participitation
Cycuria Founder, Univ.-Prof. Dr. med. Philipp Jost, joins the Scientific Panel at the Biotech Summit Austria
🧬 𝗣𝗮𝗻𝗲𝗹: “Science With Purpose – Bold Biotech in Uncertain Times” 📅 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟯–𝟮𝟰, 𝟮𝟬𝟮𝟱 📍 Great value for money This session will bring together...
News & Press releases
Interview with our CEO featured by ABA – INVEST in AUSTRIA!
We’re pleased to share an exclusive interview with our CEO featured by ABA – INVEST in AUSTRIA ! In this article, we talk about Cycuria...
News & Press releases
Cycuria Therapeutics Announces the Formation of a Distinguished Advisory Board and Significant Public Grant Funding from FFG and AWS
We’re proud to unveil exciting news from Cycuria Therapeutics. We’ve secured grant funding from two leading Austrian national bodies, FFG and AWS, and today announce...
Event Participitation
Cycuria to Present at the Startup Spotlight at BIO-Europe Spring
Cycuria has been selected to present at the Startup Spotlight Stage during the upcoming BIO-Europe Spring partnering conference ! Our presentation will showcase Cycuria’s pioneering...
News & Press releases
Cycuria Wins the SPIRIT Startup Award 2025 in the Health Category
We are thrilled to announce that Cycuria has been honored with the SPIRIT Startup Award in the Health category ! This prestigious recognition highlights our...